No abstract

No abstract

The performance of Cuban biotechnology from 2008 to 2021 has shown a growing pipeline of valuable biomedical solutions. As the transformation of this sector into an industrial group has changed its R&D productivity and bio manufacturing capacity, we summarize here the results of R&D projects with impact on public health, constraints found in Cuba, lessons, and opportunities to develop this science-based industry in developing countries.

No abstract

No abstract